Apr 4, 2016 · What are tumor markers? Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions.

2016 Drug Take-Back Day. The 11th National Prescription Drug Take-Back Day is scheduled for April 30, 2016. At these events patients can turn in prescription medications, including controlled ...

Sep 8, 2015 · How should thyroid-stimulating hormone (TSH) be managed so its levels can be maintained within the normal range after total thyroidectomy for cancer of the papillary thyroid?

Jan 10, 2025 · Patients with high-risk early breast cancer have similar survival outcomes with different dosing schedules of adjuvant anthracycline- and taxane-based chemotherapy, according to research presented ...

Nov 8, 2024 · The updated and recently published American Society of Clinical Oncology (ASCO) and Oncology Nursing Society (ONS) safety standards for administration of antineoplastic therapy provide a robust ...

Feb 28, 2018 · A patient in Germany undergoes proton therapy. At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs.

Apr 13, 2023 · Cryopreserved platelets may reduce bleeding in patients with thrombocytopenia. Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, adolescent, or young adult patients with low-risk, relapsed classic Hodgkin ...

Nov 22, 2024 · Key Question 3: Radiation therapy for symptomatic bone metastases: dose fractionation and techniques. In adult patients presenting with symptomatic bone metastases, the appropriate selection of RT ...

Feb 2, 2016 · Cancer Patients Willing to Wait for Greater Certainty That Drugs Will Provide an OS Benefit ; Reporting Pharmacogenetic Variants May Reduce Risk of Adverse Reactions to Cancer Drugs